Synapse - Robert Motzer

Results (93)

A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma

Journal Article

Carlo, M. I.; Molina, A. M.; Lakhman, Y.; Patil, S.; Woo, K.; Deluca, J.; Lee, C. H.; Hsieh, J. J.; Feldman, D. R.; Motzer, R. J.; more...
The Oncologist (2016)

Fulltext@MSK | Save

Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours

Journal Article

Karlo, C. A.; Kou, L.; Di Paolo, P. L.; Kattan, M. W.; Motzer, R. J.; Russo, P.; Tickoo, S. K.; Akin, O.; Hricak, H.
European Journal of Cancer (2016)

Fulltext@MSK | Save

Bevacizumab monotherapy as salvage therapy for advanced clear cell renal cell carcinoma pretreated with targeted drugs

Journal Article

Lee, C. H.; Hötker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K. M.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J. J.; Motzer, R. J.
Clinical Genitourinary Cancer (2016)

Fulltext@MSK | Save

A phase II trial of everolimus (E) and bevacizumab (B) in advanced non-clear cell renal cell cancer (ncRCC) to show efficacy in patients (pts) with papillary features

Meeting Abstract

Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Redzematovic, A.; Wang, P.; Lee, W.; Patil, S.; Molina, A. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma

Meeting Abstract

Lee, C. H.; Motzer, R.; Hoetker, A.; Akin, O.; Molina, A. M.; Gold, T. M.; Patil, S.; Gowrishankar, B.; Houldsworth, J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase II trial of everolimus and bevacizumab in advanced non-clear cell renal cell cancer

Meeting Abstract

Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Patil, S.; Molina, A. M.; Hsieh, J.; Motzer, R. J.; Feldman, D. R.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Bevacizumab monotherapy as salvage therapy for patients with advanced clear cell renal cell carcinoma pretreated with targeted drugs

Meeting Abstract

Lee, C. H.; Hoetker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J.; Motzer, R. J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy

Journal Article

Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
Clinical Cancer Research (2014)

Fulltext@MSK | Save

Radiogenomics of clear cell renal cell carcinoma: Associations between CT imaging features and mutations

Journal Article

Karlo, C. A.; Di Paolo, P. L.; Chaim, J.; Hakimi, A. A.; Ostrovnaya, I.; Russo, P.; Hricak, H.; Motzer, R.; Hsieh, J. J.; Akin, O.
Radiology (2014)

Fulltext@MSK | Save

Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers

Meeting Abstract

Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
Cancer Research (2013)

Fulltext@MSK | Save